Evidence map›Paper›PMID 35886051›Full record

ArticleGenes2022

A Novel Hypothesis on Choroideremia-Manifesting Female Carriers: Could

Niccolò Di Giosaffatte, Michele Valiante, Stefano Tricarico, Giulia Parise, Anna Maria De Negri, Guido Ricciotti, Lara Florean, Alessandro Paiardini, Irene Bottillo, Paola Grammatico

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Niccolò Di GiosaffatteDivision of Medical Genetics, Department of Experimental Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.ORCID 0000-0002-4913-9471
Michele ValianteDivision of Medical Genetics, Department of Experimental Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.
Stefano TricaricoASL Roma 2, 00100 Rome, Italy.
Giulia PariseDivision of Medical Genetics, Department of Experimental Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.
Anna Maria De NegriNeuro-Ophthalmology Clinic, San Camillo-Forlanini Hospital, 00152 Rome, Italy.
Guido RicciottiDepartment of Ophthalmology, University Hospital of Parma, 43126 Parma, Italy.
Lara FloreanDivision of Medical Genetics, Department of Experimental Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.
Alessandro PaiardiniDepartment of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.ORCID 0000-0001-9078-7545
Irene BottilloDivision of Medical Genetics, Department of Molecular Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.ORCID 0000-0003-0396-7981
Paola GrammaticoDivision of Medical Genetics, Department of Experimental Medicine, San Camillo-Forlanini Hospital, Sapienza University, 00185 Rome, Italy.
Carlo Forlanini Hospital · ITASL Roma · ITSapienza University of Rome · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Choroideremia is an X-linked recessive condition presenting in males, with progressive degeneration of retinal and choroidal tissues leading to progressive visual loss. Its pathological mechanism is due to alterations in the

Indexed as

ChoroideremiaRetinal DegenerationRetinitis PigmentosaAdaptor Proteins, Signal TransducingAdultFemaleHumansMaleMiddle AgedRetinaAdaptor Proteins, Signal TransducingCHM protein, humanCHMChoroideremiafemale carriermanifesting femaleREP1X-linked disease

Identifiers

PMID35886051
PMCPMC9321261
OpenAlexW4285732435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.